Influenza vaccine for patients with chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Poole, Phillippa ^a   Chacko, Emme E ^a   Wood Baker, Richard ^b   Cates, Christopher J ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF TASMANIA   (Australia)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Aged; Humans; Influenza vaccines adverse effects; *therapeutic use ; Influenza, human prevention control ; Lung diseases, obstructive * complications ; Randomized controlled trials as topic; Vaccines, attenuated adverse effects; therapeutic use ; Vaccines, inactivated adverse effects; therapeutic use

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; PLACEBO;

ANTIBODY RESPONSE; ASTHENIA; BRONCHITIS; CHEST TIGHTNESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COUGHING; DISEASE EXACERBATION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG TOLERABILITY; DYSPNEA; FEVER; FLU LIKE SYNDROME; GUILLAIN BARRE SYNDROME; HOARSENESS; HOSPITALIZATION COST; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; LUNG FUNCTION; MALAISE; MORBIDITY; MORTALITY; MYALGIA; NONHUMAN; OUTCOME ASSESSMENT; PHARYNGITIS; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; REVIEW; RHINITIS; RHINORRHEA; SIDE EFFECT; SNEEZING; SPUTUM; SYSTEMATIC REVIEW; THORAX PAIN; WHEEZING;

EID: 77950178503     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002733.pub2     Document Type: Review

References (57)

1. Cate 1977 {published data only} * Cate TR, Kasel JA, Couch RB, Six HR, Knight V. Clinical trials of bivalent influenza/A/New Jersey/76-A/Victoria/75 vaccines in the elderly. Journal of Infectious Diseases 1977;136(Suppl):S518-25.
2. Fell 1977 {published data only} Fell PJ, O'Donnell HF, Watson NP, Simmins RL, Hasell SK. Longer term effects of live influenza vaccine in patients with chronic pulmonary disease. Lancet 1977;1(8025): 1282-4.
3. Gorse 1995 {published data only} Gorse GJ, Campbell MJ, Otto EE, Powers DC, Chambers GW, Newman FK. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically elderly with live attenuated or inactivated influenza virus vaccine. Journal of Infectious Diseases 1995;172:1-10.
4. Gorse 1997 {published data only} Gorse GJ, Otto EE, Daughaday CC, Newman FK, Eickhoff CS, Powers DC, et al.Influenza virus vaccination of patients with chronic lung disease. Chest 1997;112(5):1221-33.
5. Gorse 2003 {published data only} Gorse GJ, O'Connor TZ, Young SL, et al.Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease : a VA cooperative study. Vaccine 2003;21:2133-44.
6. Gorse 2006 {published data only} Gorse GJ, O'Connor TZ, Young SL, Habib MP, Wittes J, Neuzil KM, Nichol KL. Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. Chest 2006;130:1109-1116.
7. Govaert 1993 {published data only} Govaert ME, Dinant GJ, Aretz K, Masurel N, Sprenger MJW, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people:randomised double blind placebo controlled trial. BMJ 1993;307:988-90.
8. Govaert 1994 {published data only} Govaert ME, Thijs CT, Masurel N, Sprenger JW, Dinant GJ, Knottnerus JA. The efficacy of Inflenza vaccination in elderly individuals-a randomised double-blind placebo controlled trial. JAMA 1994;272(21):1661-5.
9. Howells 1961 {published data only} Howells CHL, Tyler LE. Prophylactic use of influenza vaccine in patients with chronic bronchitis. A pilot trial. Lancet 1961;2:1428-32.
10. MRC 1980 {published data only} * Advisory Group on Pulmonary Function Tests in Relation to Live Influenza Virus Vaccines. A study of live influenza virus vaccine in patients with chronic bronchitis. Report to Medical Research Council's committee on influenza and other respiratory virus vaccines.. British Journal of Diseases of the Chest 1980;74(2): 121-7.
11. Neuzil 2003 {published data only} Neuzil KM, O'Connor TZ, Gorse GJ, Nichol KL. Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine. Clinical Infectious Diseases 2003;36(2):169-74.
12. Treanor 1992 {published data only} Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, et al.Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Annals of Internal Medicine 1992;117:625-33.
13. Treanor 1994 {published data only} Treanor J, Dumyati G, O'Brien D, Riley M, Riley G, Erb S, et al.Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults. Journal of Infectious Diseases 1994;169:402-7.
14. Wongsurakiat 2003 {published data only} Wongsurakiat P, Lertakyamanee J, Maranetra KN, Jongriratanakul S, Sangkaew S. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. Journal of the Medical Association of Thailand 2003;86(6):497-508.
15. Wongsurakiat 2004 {published and unpublished data} Wongsurakiat P, Maranetra KN, Wasi C, et al.Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004;125:2011-20.
16. Wongsurakiat 2004/2 {published data only} Wongsurakiat P, Maranetra KN, Gulprasutdilog P, et al.Adverse effects associated with influenza vaccination in patients with COPD:a randomized controlled study. Respirology 2004;9:550-6.
17. Ambrosch 1979 {published data only} Ambrosch F, Konigstein RP, Olbrich E, Potschka W, Wiedermann G. Influenza immunisation, clinical results and serological tests [Klinische und serlogische Untersuchungen zur Wirkung der Influenzaimpfung]. Aktuelle Gerontologie 1979;9:399-404.
18. Centanni 1997 {published data only} * Centanni S, Pregliasco F, Bonfatti C, Mensi C, Tarsia P, Guarnieri R, et al.Clinical efficacy of a vaccine-immunostimulant combination in the prevention of influenza in patients with chronic obstructive pulmonary disease. Journal of Chemotherapy 1997;9(4):273-8.
19. Dorrell 1997 {published data only} Dorrell L, Hassan I, Marshall S, Chakraverty P, Ong E. Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults, and healthy volunteers. International Journal of STD and AIDS 1997;8:776-9.
20. Gorse 1986 {published data only} Gorse GJ, Belse RB, Munn NJ. Safety of serum and antibody response to cold- recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases. Journal of Clinical Microbiology 1986;24(3):336-42.
21. Gorse 1988 {published data only} * Gorse GJ, Belshe RB, Munn NJ. Local and systemic antibody response in high-risk adults given live-attenuated and inactivated A virus vaccines. Journal of Clinical Microbiology 1988;26(5):911-8.
22. Gorse 1991 {published data only} Gorse GJ, Belshe RB, Munn NJ. Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults. Chest 1991;100(4):977-84.
23. Gorse 1996 {published data only} Gorse GJ, Otto EE, Powers DC, Chambers GW, Eickhoff CS, Newman FK. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. Journal of Infectious Diseases 1996;173:285-90.
24. Howells 1975 {published data only} Howells CHL, Vesselinova-Jenkins CK, Evans AD, James J. Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet 1975;1(7903):381-3.
25. Keitel 1993 {published data only} Keitel WA, Couch RB, Quarles JM, Cate TR, Baxter B, Maassab HF. Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults. Journal of Infectious Diseases 1993;167:305- 11.
26. Lama 1998 {published data only} Lama A, Tatliei G, Aydin Tosun G, Yildirim N. [Preventive effect of influenza vaccine on chronic obstructive pulmonary disease and bronchial asthma]. FirstWorld Congress on Vaccines and Immunisation, Istanbul, Turkey. 1998.
27. Margolis 1990 {published data only} Margolis KL, Poland GA, Nichol KL, MacPherson DS, Meyer JD, Kron JE, et al.Frequency of adverse reactions after influenza vaccination. American Journal of Medicine 1990;88:27-30.
28. MRC 1959 {published data only} Medical Research Council. Field trial of influenza virus vaccine in patients with chronic bronchitis during the winter 1957-8. BMJ 1959;2:905-8.
29. MRC 1984 {published data only} Medical Research Council. Trials of live attenuated influenza virus vaccine in patients with chronic airways disease. British Journal of Diseases of the Chest 1984;78:236-47.
30. Paul 1988 {published data only} Paul WS, Cowan J, Jackson GG. Acute respiratory illness among immunised and non-immunised patients with high-risk factors during a split season of influenza A and B. Journal of Infectious Diseases 1988;157(4):633-9.
31. Portari 1998 {published data only} * Portari Mancini DA, Zucatelli Mendonca RM, Zucatelli Mendonca R, Amaral do Prado J, de Meol Andrade C. Immune response to vaccine against influenza in smokers, non-smokers and in individuals holding respiratory complications. Bollettino Chimico Farmaceutico 1998;137(1):21-5.
32. Powers 1991 {published data only} Powers DC, Fries LF, Murphy BR, Thumar B, Clements ML. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory. Journal of Clinical Microbiology 1991;29(3):498-505.
33. Prevost 1975 {published data only} Prevost JM, Vereerstraeten-Schmerber J, Lamy F, De Koster JP. Live attenuated influenza virus vaccines in patients with chronic broncho-pulmonary diseases. Scandinavian Journal of Respiratory Diseases 1975;56:58-69.
34. Saah 1986 {published data only} Saah AJ, Neufeld R, Rodstein M, La Montagne JR, Blackwelder WC, Gross P. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine 1986;146(12):2353-7.
35. Treanor 1998 {published data only} Treanor JJ, Betts RF. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects. Vaccine 1998;16(18):1756-60.
36. Winson 1977 {published data only} Winson IG, Smit JM, Potter CW, Howard P. Studies with live attenuated influenza virus in chronic bronchitis. Thorax 1977;32:726-8.
37. ACIP 1999 Advisory Committee on Immunization Practises (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 1999;48(RR-4):1-28.
38. ATS 1995 ATS. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 1995;Suppl:S77-S120.
39. BRFSS 1998 Behavioural Risk Factor Surveillance System. Influenza and pneumococcal vaccination levels among adults aged > 65 years-United States 1997. Morbidity & Mortality Weekly Report 1998;47(38): 797-802.
40. BTS 1997 British Thoracic Society. COPD guidelines group of the standards of care committee of the BTS.BTS Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52:S7-S15.
41. Clark 1999 Clark HD, Wells GA, Huet C, McAlister FA, Salmi LR, Fergusson D, et al.Assessing the quality of randomised trials: reliability of the Jadad Scale. Controlled Clinical Trials 1999;20:448-52.
42. Galasso 1977 Galasso GJ, Tyeryar FJ, La Montagne JR. Overview of clinical trials of influenza vaccines 1976. Journal of Infectious Diseases 1977;136(Suppl):S425-8.
43. Gross 1989 Gross PA, Quinnan GV, Weksler ME, Setia U, Douglas RG. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine 1989;7:303-8.
44. Gross 1995 Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. Annals of Internal Medicine 1995;123:518-27.
45. Jadad 1996 Jadad A, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al.Assessing the quality of reports of randomised controlled trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
46. La Montagne 1978 La Montagne JR, Noble GR, Quinnan GV, Curlin GT, Blackwelder WC, Smith J, et al.Summary of clinical trials of inactivated influenza vaccine -1978. Reviews of Infectious Diseases 1983;5(4):723-36.
47. Moher 1996 Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials:current issues and future directions. International Journal of Technology Assessment in Health Care 1996;12:195-208.
48. Monto 1987 Monto AS. Influenza: quantifying morbidity and mortality. American Journal of Medicine 1987;82(Suppl 6A):20-5.
49. Nichol 1994 Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine 1994;331:778-84.
50. Nichol 1995 Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, et al.The effectiveness of vaccination against influenza in healthy working adults. New England Journal of Medicine 1995;333:889-93.
51. Nichol 1998 Nichol KL, Wuorenma J, von Stenberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine 1998;158:1769-76.
52. Nichol 1999 Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Annals of Internal Medicine 1999;130:397-403.
53. NIH 1976 Wright PF, Dolin R, La Montagne JR. From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines - II. Journal of Infectious Diseases 1976;134(6):633-8.
54. Patriarca 1994 Patriarcha PA. A randomised controlled trial of influenza vaccine in the elderly. JAMA 1994;272(21):1700-1.
55. Rothbart 1995 Rothbart PH, Kempen BM, Sprenger MJW. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 1995;151:1682-6.
56. Siafakas 1995 Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, et al.Optimal assessment and management of chronic obstructive pulmonary disease (COPD). European Respiratory Journal 1995;8:1398-420.
57. Watson 1997 Watson JM, Cordier JF, Nicholson KG. Does influenza immunisation cause exacerbations of chronic airflow obstruction or asthma?. Thorax 1997;52:190-4.